GlaxoSmithKline and Curevac said a study of Macaque monkeys showed the Covid-19 MRNA vaccine candidate developed jointly for "greatly enhanced"…
CureVac stocks dropped by up to 52 percent on Thursday following the German biotech's Covid-19 vaccine demonstrated just 47% successful…
German biotech CureVac NV said on Wednesday its own Covid-19 vaccine was just 47% successful in an late-stage trial, inducing…
The German company CureVac delivered disappointing preliminary results Wednesday from a clinical trial of its covid-19 vaccine, dimming hopes that…